Vipul Gupta
About Vipul Gupta
Vipul Gupta is a Staff Scientist currently serving as Senior Director at Spero Therapeutics, Associate Director at Acceleron Pharma, and Staff Scientist at Alkermes, with extensive experience in DMPK, BA, and Clinical Pharmacology.
Current Roles
Vipul Gupta currently holds several prominent positions in the pharmaceutical industry. He is the Senior Director of DMPK, BA, and Clinical Pharmacology at Spero Therapeutics in Cambridge, MA. Additionally, he is an Associate Director at Acceleron Pharma in Cambridge, MA, and a Staff Scientist at Alkermes in Waltham, MA.
Previous Positions
Vipul Gupta has a substantial career history in the pharmaceutical industry. He worked as a Senior Scientist I at Cubist Pharmaceuticals from 2011 to 2015 in Lexington, MA. Before that, he was a Senior Research Investigator and Senior Scientist at Eisai from 2008 to 2011 in Andover, MA. Earlier, he served as a Research Investigator at Eisai Research Institute from 2007 to 2008, also in Andover, MA.
Education and Expertise
Vipul Gupta has an extensive educational background in pharmacokinetics. He completed his Post Doctoral Fellowship at the University of Florida from 2005 to 2007. Prior to that, he studied at Birla Institute of Technology and Science, Pilani, from 1994 to 1998. He has over 20 publications and expertise in both non-compartmental and compartmental pharmacokinetics for preclinical and clinical studies.
Regulatory and Technical Proficiency
Vipul Gupta is proficient in writing submission-quality reports and Common Technical Document (CTD) documents for IND and NDA submissions. He is experienced in managing outsourced DMPK studies and collaborating with internal and external drug discovery and development teams. His knowledge extends to regulatory guidelines from the FDA and EMA, including MIST, DDI, and exposure-response.
Leadership and Communication Skills
Vipul Gupta has demonstrated effective communication and leadership skills, particularly in mentoring and coaching junior staff on aspects of DMPK. He is known for his ability to impact project teams positively as a DMPK discipline leader and resolve project-related issues efficiently. He has a proven track record in drug discovery and development across multiple therapeutic areas, including oncology, immunology, pain, and anti-infectives.